Alterations of coagulation pathway parameters in children with sickle cell disease (SCD)

被引:0
|
作者
Hatzipantelis, ES [1 ]
Athanassiou-Metaxa, M [1 ]
Taparkou, A [1 ]
Kleta, D [1 ]
Gerotziafa, T [1 ]
Gombakis, N [1 ]
Tsatra, I [1 ]
Koussi, A [1 ]
Tsantali, H [1 ]
Garipidou, V [1 ]
Kanakoudi-Tsakalidou, F [1 ]
机构
[1] Aristotle Univ Thessaloniki, Paediat Dept 1, Thalassemia Unit, Gen Haematol Lab, Thessaloniki, Greece
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A large number of coagulation abnormalities have been described in SCD. Thus, activation of coagulation has been shown to be a feature of this disorder, both in the steady state and during painful crisis, with rates of thrombin and fibrin formation constantly higher than normal. In this study we determined the levels of several coagulation pathway parameters in 38 children and adolescents with SCD during steady state, and in 16 during thrombotic crisis. In patients during steady state we found significantly increased levels of D-dimers, and decreased levels of A2-antiplasmin, compared with healthy controls. In patients during thrombotic crisis we found significantly increased levels of D-dimers and VWF, and decreased levels of TT, compared with healthy controls and patients in steady state. These findings confirms the serious dysfunction of coagulation pathway during thrombotic crisis, while pathologic values in some of them during steady state shows the presence of chronic inflammation and activation of coagulation in SCD patients.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 50 条
  • [1] Coagulation disorders in children with sickle cell disease (SCD) and cerebrovascular accident (CVA)
    Barrios, N
    Reyes, C
    Borrero, PS
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2965 - P2965
  • [2] Parameters of vitamin A (VA) status in children with sickle cell disease (SCD)
    Park, Hyunjin
    Schall, Joan
    Zemel, Babette
    Kawchak, Deborah
    Ohene-Frempong, Kwaku
    Green, Michael H.
    Stallings, Virginia
    FASEB JOURNAL, 2009, 23
  • [3] COAGULATION ABNORMALITIES IN CHILDREN WITH SICKLE-CELL DISEASE (SCD) AND CEREBROVASCULAR ACCIDENT (CVA)
    BARRIOS, N
    BAGTAS, J
    GRANA, N
    ROSSBACH, C
    BARBOSA, J
    BLOOD, 1993, 82 (10) : A469 - A469
  • [4] Hydroxyurea in children with sickle cell disease (SCD).
    Olivieri, NF
    Basran, R
    NisbetBrown, E
    Blanchette, N
    Styles, L
    Talbot, A
    Das, M
    HackneyStephens, E
    Kleman, K
    Vichinsky, EP
    BLOOD, 1996, 88 (10) : 2473 - 2473
  • [5] Pancreatitis in children with sickle cell disease (SCD)
    Sakhalkar, VS
    Miller, ST
    Rao, SP
    Sakhalkar, MV
    Rabinowitz, SS
    PEDIATRIC RESEARCH, 2004, 55 (04) : 307A - 307A
  • [6] Cholecystectomy in children with sickle cell disease(SCD)
    Sakhalkar, VS
    Miller, ST
    Rao, SP
    Sakhalkar, MV
    Rabinowitz, SS
    PEDIATRIC RESEARCH, 2004, 55 (04) : 307A - 307A
  • [7] Energy balance in children with sickle cell disease (SCD).
    Barden, EM
    Zemel, BS
    Kawchak, DA
    Goran, MI
    Ohene-Frempong, K
    Stallings, VA
    AMERICAN JOURNAL OF HUMAN BIOLOGY, 1999, 11 (01) : 104 - 104
  • [8] Antioxidant status in children with sickle cell disease (SCD)
    Kawchak, DA
    Zemel, BS
    Sowell, AL
    Ohene-Frempong, K
    Stallings, VA
    FASEB JOURNAL, 1999, 13 (05): : A701 - A701
  • [9] Activation of coagulation in children with sickle cell disease
    Setty, BNY
    Colman, RW
    Dampier, C
    Kulkarni, S
    Moss, S
    O'Neal, P
    Polansky, M
    Rao, AK
    Scott, CF
    Sun, L
    Stuart, MJ
    THROMBOSIS AND HAEMOSTASIS, 1999, : 114 - 114
  • [10] Role of hydroxyurea (HU) in children with sickle cell disease (SCD)
    Motwani, J
    Lawson, SE
    Darbyshire, PJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 24 - 25